Trial Profile
A phase II study of weekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancer
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 Feb 2018
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Ramucirumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 16 Feb 2018 New trial record